Velo-1 Overview
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
1
Velo-1 General Information
Description
Developer of companion animal therapeutics intended to address health needs in veterinary care. The company is currently operating in Stealth mode.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
- TN
- United States
Primary Industry
Drug Discovery
Corporate Office
- TN
- United States
Velo-1 Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 01-Jan-2025 | Completed | Stealth |
Velo-1 Patents
Velo-1 Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026142920-A2 | Treating or preventing pain and/or inflammation and/or controlling pyrexia/fever with (s)-6-chloro-7-(1,1-dimethylethyl)-2-trifluoromethyl-2h-1-benzopyran-3-carboxylic acid or a salt thereof or a hydrate thereof | Pending | 27-Dec-2024 |
Velo-1 Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Mountain Group Partners | Venture Capital | Minority |
Velo-1 FAQs
-
Where is Velo-1 headquartered?
Velo-1 is headquartered in TN.
-
What industry is Velo-1 in?
Velo-1’s primary industry is Drug Discovery.
-
Is Velo-1 a private or public company?
Velo-1 is a Private company.
-
What is Velo-1’s current revenue?
The current revenue for Velo-1 is .
-
Who are Velo-1’s investors?
Mountain Group Partners has invested in Velo-1.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process